BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 9554639)

  • 21. Comparing approaches to the management of malignant pleural effusions.
    Porcel JM; Lui MM; Lerner AD; Davies HE; Feller-Kopman D; Lee YC
    Expert Rev Respir Med; 2017 Apr; 11(4):273-284. PubMed ID: 28271728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thoracoscopy talc poudrage : a 15-year experience.
    de Campos JR; Vargas FS; de Campos Werebe E; Cardoso P; Teixeira LR; Jatene FB; Light RW
    Chest; 2001 Mar; 119(3):801-6. PubMed ID: 11243960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thoracoscopic management of malignant pleural effusions.
    Colt HG
    Clin Chest Med; 1995 Sep; 16(3):505-18. PubMed ID: 8521705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of talc pleurodesis is associated with increased pleural fibrinolysis.
    Rodriguez-Panadero F; Segado A; Martin Juan J; Ayerbe R; Torres Garcia I; Castillo J
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):785-90. PubMed ID: 7881671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of malignant pleural effusions.
    Sahn SA
    Monaldi Arch Chest Dis; 2001 Oct; 56(5):394-9. PubMed ID: 11887496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleurodesis for malignant pleural effusions.
    Shaw P; Agarwal R
    Cochrane Database Syst Rev; 2004; (1):CD002916. PubMed ID: 14973997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Talc pleurodesis for the management of malignant pleural effusions in Japan.
    Inoue T; Ishida A; Nakamura M; Nishine H; Mineshita M; Miyazawa T
    Intern Med; 2013; 52(11):1173-6. PubMed ID: 23728550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting.
    Petrou M; Kaplan D; Goldstraw P
    Cancer; 1995 Feb; 75(3):801-5. PubMed ID: 7530167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.
    Burrows CM; Mathews WC; Colt HG
    Chest; 2000 Jan; 117(1):73-8. PubMed ID: 10631202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial.
    Bhatnagar R; Laskawiec-Szkonter M; Piotrowska HE; Kahan BC; Hooper CE; Davies HE; Harvey JE; Miller RF; Rahman NM; Maskell NA
    BMJ Open; 2014 Nov; 4(11):e007045. PubMed ID: 25428632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monitoring the effectiveness of surgical treatment of malignant pleural effusions].
    Habal P; Mand'ák J; Simek J; Stĕtina M; Jankovicová K; Kondĕlková K; Krejsek J
    Klin Onkol; 2010; 23(2):99-103. PubMed ID: 20465088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
    Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Video-assisted talc pleurodesis for malignant pleural effusions utilizing local anesthesia and I.V. sedation.
    Danby CA; Adebonojo SA; Moritz DM
    Chest; 1998 Mar; 113(3):739-42. PubMed ID: 9515851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Talc pleurodesis in malignant pleural effusions].
    Kolschmann S; Ballin A; Juergens UR; Rohde G; Gessner C; Hammerschmidt S; Wirtz H; Gillissen A
    Pneumologie; 2006 Feb; 60(2):89-95. PubMed ID: 16463249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid pleurodesis for malignant pleural effusions: a pilot study.
    Reddy C; Ernst A; Lamb C; Feller-Kopman D
    Chest; 2011 Jun; 139(6):1419-1423. PubMed ID: 20930006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary treatment of malignant pleural effusions: video-assisted thoracoscopic surgery poudrage versus tube thoracostomy.
    Erickson KV; Yost M; Bynoe R; Almond C; Nottingham J
    Am Surg; 2002 Nov; 68(11):955-9; discussion 959-60. PubMed ID: 12455787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effective treatment of malignant pleural effusion: Thoracoscopic talcum pleurodesis and pleuro-peritoneal shunt].
    Böhle AS; Kurdow R; Dohrmann P; Henne-Bruns D
    Dtsch Med Wochenschr; 1999 Mar; 124(12):341-5. PubMed ID: 10214366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant pleural effusions: recourse to early use of talc].
    Viallat JR; Boutin C
    Rev Med Interne; 1998 Nov; 19(11):811-8. PubMed ID: 9864779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thoracoscopic talc pleurodesis for malignant pleural effusion.
    Love D; White D; Kiroff G
    ANZ J Surg; 2003; 73(1-2):19-22. PubMed ID: 12534732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.